MYO19 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.066000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.361600E-01
Normal-vs-Stage2
2.853200E-01
Normal-vs-Stage3
7.196400E-01
Normal-vs-Stage4
3.513600E-01
Stage1-vs-Stage2
5.892600E-01
Stage1-vs-Stage3
7.819600E-01
Stage1-vs-Stage4
7.028400E-01
Stage2-vs-Stage3
4.614400E-01
Stage2-vs-Stage4
4.736200E-01
Stage3-vs-Stage4
9.812200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.947000E-01
Normal-vs-AfricanAmerican
5.238000E-01
Normal-vs-Asian
3.472000E-01
Caucasian-vs-AfricanAmerican
6.533600E-01
Caucasian-vs-Asian
5.444400E-01
AfricanAmerican-vs-Asian
5.055000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.121400E-01
Normal-vs-Female
3.090800E-01
Male-vs-Female
8.000200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.757400E-01
Normal-vs-Age(41-60Yrs)
1.762650E-01
Normal-vs-Age(61-80Yrs)
3.850000E-01
Normal-vs-Age(81-100Yrs)
2.827400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.443200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.751000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.556000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.314800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.168000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.771600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.546000E-01
Normal-vs-Daily Drinker
4.312600E-01
Normal-vs-Weekly Drinker
1.593400E-01
Normal-vs-Occasional Drinker
1.374030E-01
Normal-vs-Social Drinker
1.259170E-01
Non Drinker-vs-Daily Drinker
6.863200E-01
Non Drinker-vs-Weekly Drinker
6.416800E-01
Non Drinker-vs-Occasional Drinker
2.576600E-01
Non Drinker-vs-Social Drinker
4.512600E-01
Daily Drinker-vs-Weekly Drinker
4.026600E-01
Daily Drinker-vs-Occasional Drinker
1.425770E-01
Daily Drinker-vs-Social Drinker
2.602200E-01
Weekly Drinker-vs-Occasional Drinker
5.409600E-01
Weekly Drinker-vs-Social Drinker
7.777400E-01
Occasional Drinker-vs-Social Drinker
7.230000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.596570E-01
Normal-vs-Grade 2
1.217790E-01
Normal-vs-Grade 3
4.864200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.999600E-03
Grade 1-vs-Grade 3
5.154800E-04
Grade 1-vs-Grade 4
1.596570E-01
Grade 2-vs-Grade 3
4.049400E-01
Grade 2-vs-Grade 4
1.217790E-01
Grade 3-vs-Grade 4
4.864200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.045000E-01
Normal-vs-NonDiabetic
2.356800E-01
Diabetic-vs-NonDiabetic
3.069800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.956010E-02
Normal-vs-NoPancreatitis
3.561000E-01
Pancreatitis-vs-NoPancreatitis
5.058000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.147000E-01
Normal-vs-N1
3.327400E-01
N0-vs-N1
5.561000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.766410E-04
Normal-vs-TP53-NonMutant
5.336000E-01
TP53-Mutant-vs-TP53-NonMutant
1.54971999999365E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
